Trials / Unknown
UnknownNCT05401006
Effect of Acitretin Versus Narrowband Ultraviolet B on Neopterin Level in Psoriatic Patients .
Evaluation of the Effect of Acitretin Versus Narrowband Ultraviolet B on Serum Neopterin Level in Psoriatic Patients .
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- South Valley University · Academic / Other
- Sex
- All
- Age
- 15 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate effect of acitretin versus Narrowband UVB on serum level of neopterin in psoriatic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acitretin 25Mg Cap | Acitretin is an oral retinoid (a derivative of vitamin A) given in a dose 0.25-1 mg /kg/day for 3months in psoriatic patients |
| RADIATION | Narrowband ultraviolet B | Narrowband UVB is the most common form of phototherapy used to treat psoriasis, given 2-3 sessions per week for 3 successive months |
Timeline
- Start date
- 2021-06-05
- Primary completion
- 2022-06-05
- Completion
- 2023-06-05
- First posted
- 2022-06-02
- Last updated
- 2022-06-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05401006. Inclusion in this directory is not an endorsement.